[Answer to "Comment on the article: "Diagnostic performance of the FINDRISC questionnaire to identify insulin resistance in adults""].

Yuline Varela-Vega, Ivonne Analí Roy-García, Marcela Pérez-Rodríguez, Lubia Velázquez-López
{"title":"[Answer to \"Comment on the article: \"Diagnostic performance of the FINDRISC questionnaire to identify insulin resistance in adults\"\"].","authors":"Yuline Varela-Vega, Ivonne Analí Roy-García, Marcela Pérez-Rodríguez, Lubia Velázquez-López","doi":"10.5281/zenodo.14616836","DOIUrl":null,"url":null,"abstract":"<p><p>The FINDRISC instrument has been established as a screening tool to determine the risk of developing type 2 diabetes (T2D) at 10 years. However, the established cut-off points were based on a population with a low prevalence of the disease, unlike the Mexican population in which, based on the latest ENSANUT 2022 report, the global prevalence of T2D is 18.3%. Based on this, the need arose to establish a cut-off point to identify the presence of insulin resistance in this population using the FINDRISC instrument. And, in this way, identify the population one step before the development of T2D.</p>","PeriodicalId":94200,"journal":{"name":"Revista medica del Instituto Mexicano del Seguro Social","volume":"63 2","pages":"e5034"},"PeriodicalIF":0.0000,"publicationDate":"2025-03-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12037138/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Revista medica del Instituto Mexicano del Seguro Social","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5281/zenodo.14616836","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

The FINDRISC instrument has been established as a screening tool to determine the risk of developing type 2 diabetes (T2D) at 10 years. However, the established cut-off points were based on a population with a low prevalence of the disease, unlike the Mexican population in which, based on the latest ENSANUT 2022 report, the global prevalence of T2D is 18.3%. Based on this, the need arose to establish a cut-off point to identify the presence of insulin resistance in this population using the FINDRISC instrument. And, in this way, identify the population one step before the development of T2D.

[对“FINDRISC问卷对成人胰岛素抵抗的诊断性能”一文的评论]。
FINDRISC仪器已被确立为确定10岁时发生2型糖尿病(T2D)风险的筛查工具。然而,既定的分界点是基于疾病患病率较低的人群,与墨西哥人口不同,根据最新的ENSANUT 2022报告,墨西哥人口的T2D全球患病率为18.3%。基于此,有必要使用FINDRISC仪器建立一个分界点,以确定该人群中胰岛素抵抗的存在。通过这种方式,在T2D发展前一步确定人群。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信